期刊文献+

中西医结合治疗慢性肝衰竭多地域、多中心、随机、对照研究 被引量:4

A multiregional,multicenter,randomized and controlled study on the treatment of chronic liver failure by combined traditional Chinese and western medicine
下载PDF
导出
摘要 目的观察中西医结合治疗方案对慢性肝衰竭患者病死率、并发症发生率以及中医症状改善率的影响。方法采用随机对照设计,将纳入对象随机分配入试验组和对照组,分别给予中西医结合和内科综合治疗。结果经χ2检验,在治疗第8周、第12周、第24周和第48周,2组病死率差异无统计学意义,生存分析表明试验组的生存率略低于对照组,但经Log-rank检验,2组生存曲线差异无统计学意义;治疗第5周、第6周、第7周及第24周4个时间点试验组腹水发生率低于对照组(P<0.05),在治疗第48周试验组的肝性脑病发生率低于对照组(P<0.05);在改善乏力、腹胀、水肿等中医临床症状方面试验组优于对照组。结论个体化复杂干预的中西医结合治疗方案与单纯西医治疗比较,在降低慢性肝衰竭病死率方面未显示出优势,但在控制腹水、肝性脑病等并发症方面有一定作用,特别是在改善中医症状方面具有明显优势。 Objective To observe the effect of combined traditional Chinese medicine (TCM) and western medicine therapy on the mortality rate, the incidence of complications and the improvement in TCM symptoms in patients with chronic liver failure. Methods A randomized controlled study was carried out. The subjects were randomly divided into an experimental group and a control group. The patients in the experimental group underwent the combined TCM and western medicine therapy, and those in the control group underwent conventional internal treatment. Results Log-rank test showed the mortality rates were not significantly different between the two groups at week 8, 12, 24 and 48 (P〉0.05). The survival analysis showed that the survival rate of the patients in the experimental group was a little lower than that of the control group, however, the difference in the survival curve between the two groups was not significant by testing the homogeneity of survival curves (P〉0.05). The incidence rate of ascites in experimental group was significantly lower than that in the control group at week 5, 6, 7 and 24 (P〈0.05), and the incidence rate of hepatic encephalopathy in the experimental group was also significantly lower than that in the control group at week 48 (P〈0.05). The TCM clinical symptoms such as fatigue malaise, abdominal distension, edema and so on in the experimental group improved more greatly than those in the control group. Conclusions Compared with single western medicine therapy, the individualized, complex and interventional therapeutic regimen of combined TCM and western medicine shows no obvious advantages in reducing the mortality rate of patients with chronic liver failure, but has certain effect on the inhibition of the incidence of ascites, hepatic encephalopathy and other complications, especially it has the obvious advantage in the improvement of TCM symptoms.
出处 《传染病信息》 2012年第3期155-157,共3页 Infectious Disease Information
基金 国家"十一五"科技重大专项(2008ZX10005-007) 军队"十一五"中医药研发推广专项重大临床攻关项目(2006231001)
关键词 中西医结合 肝功能衰竭 治疗结果 integrated traditional Chinese and western medicine therapy liver failure therapeutic outcome
  • 相关文献

参考文献13

二级参考文献73

共引文献154

同被引文献57

  • 1宁琴,陈韬,严伟明.免疫系统在病毒性肝炎肝脏损伤中的作用[J].肝脏,2007,12(S1):6-10. 被引量:6
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 3李筠.慢性重型肝炎中医证候特点及其演变规律[C].世界中联第五届肝病国际学术大会深圳,2013. 被引量:1
  • 4JALAN R, GINES P, OLSON JC, et al. Acute -on chronic liver failure[J]. J Hepatol, 2012, 57(6): 1336-1348. 被引量:1
  • 5OLSON JC, KAMATH PS. Acute - on - chronic liver failure.. concept, natural history, and prognosis [ J]. Curr Qpin Ctit Care, 2011 , 17(2) : 165 -169. 被引量:1
  • 6李筠.王立福.重型肝炎中西医结合治疗的综合分析与评价[C].中华中医药学会第十三届内科肝胆病学术会议杭州,2008. 被引量:1
  • 7李筠,王立福,李丰衣,等.慢性重型肝炎证候规律及中西医结合治疗方案研究[C].第二十次全国中西医结合肝病学术会议.张家界.2011. 被引量:1
  • 8李筠,王立福.肝衰竭中西医结合治疗经验分享[C].第7届全国疑难及重症肝病大会.北京,2013. 被引量:1
  • 9SAWA H, UEDA T, TAKEYAMA Y, et al. Role of toll -like " - receptor 4 in the pathophysiology of severe acute pancreatitis in mice [J]. Surg Today, 2007, 37110). 867-873. 被引量:1
  • 10李筠.内毒素在肝衰竭形成中的作用及中西医结合治疗[c].全国中西医防治感染病新进展学习班龙岩.2014. 被引量:1

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部